Tag: Karyopharm Therapeutics Inc

Finance

Healthcare most active stocks: Orexigen Therapeutics (NASDAQ:OREX), Express Scripts Holding (NASDAQ:ESRX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Novavax (NASDAQ:NVAX), Bristol-Myers Squibb (NYSE:BMY)

According to a statement of Orexigen Therapeutics, Inc. (NASDAQ:OREX), the U.S Food and Drug Administration hasn’t given a green signal to its new drug which helps people in fighting from obesity. One of the spokespersons of the company said,” FDA has delayed its decision on our drug for as much as 3 months. So we will be able to get a final call only after … Continue reading Healthcare most active stocks: Orexigen Therapeutics (NASDAQ:OREX), Express Scripts Holding (NASDAQ:ESRX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Novavax (NASDAQ:NVAX), Bristol-Myers Squibb (NYSE:BMY)

Jayne Crisman
Finance

Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance was 0.22% in last session and finished the day at $13.94. Traded volume was million shares in the last session and the average volume of the stock remained 815.19K … Continue reading Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Colin Pettis